Longboard Pharmaceuticals... (LBPH)
NASDAQ: LBPH
· Real-Time Price · USD
59.98
null (null%)
At close: Nov 29, 2024, 7:00 PM
Longboard Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -76.34M | -64.74M | -57.95M | -54.42M | -50.73M | -49.4M | -45.8M | -43.95M | -41.37M | -36.12M | -31.7M | -27.8M | -29.13M | -25.34M | -19.93M |
Depreciation & Amortization | 5K | 5K | 5K | 5K | 5K | 5K | 5K | 5K | 5K | 4K | 2K | 1K | n/a | n/a | n/a |
Stock-Based Compensation | 8.79M | 6.27M | 4.31M | 3.25M | 2.99M | 2.92M | 2.78M | 2.66M | 2.65M | 2.39M | 2.21M | 1.97M | 8.74M | 8.7M | 8.75M |
Other Working Capital | 2.77M | 4.8M | 2.75M | 1.57M | -819K | -527K | 3M | 2.84M | 4.69M | 3.38M | 2.33M | 1.15M | -1.01M | 326K | -1.46M |
Other Non-Cash Items | 1.16M | -2.41M | -1.11M | -972K | -737K | -420K | -45K | 101K | 20.84M | 20.87M | 20.86M | 20.78M | 1.29M | 1.27M | 1.27M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -20.56M | -20.56M | -20.56M | -20.56M | n/a | n/a | n/a |
Change in Working Capital | 3.54M | 5.33M | 3.51M | 1.27M | -1.03M | 811K | 1.93M | 3.12M | 4.37M | 3.07M | 2.2M | 967K | -241K | 1.24M | 30K |
Operating Cash Flow | -65.93M | -58.63M | -52.95M | -50.87M | -49.51M | -46.08M | -41.13M | -38.06M | -34.07M | -30.35M | -26.98M | -24.7M | -20.49M | -15.4M | -11.15M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3K | -16K | -16K | -16K | -13K | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -434.62M | -391.32M | -306.27M | -71.72M | -59.82M | -57.73M | -56.9M | -57.61M | -54.28M | -46.98M | -61.98M | -40.7M | -37.26M | -28.01M | n/a |
Sales Maturities Of Investments | 214.5M | 149.9M | 93.5M | 95.95M | 87.76M | 74.8M | 67.2M | 40.55M | 31.64M | 14.2M | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -20.92M | -20.91M | -212.77K | 24.23K | 27.94K | 17.07K | 10.3K | -21.28M | -24.72M | -24.73M | -52.75M | -31.46M | -28.02M | -28.01M | n/a |
Investing Cash Flow | -220.12M | -241.42M | -212.77M | 24.23M | 27.94M | 17.07M | 10.3M | -17.06M | -22.65M | -32.8M | -62M | -40.72M | -37.28M | -28.01M | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1K | 1K | 1K | 1K | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -14.18M | -14.76M | -14.9M | -1.6M | -2.22M | -2.21M | -2.08M | -444K | 8.32M | 8.32M | 6.72M | n/a | -7.76M | -6.84M | -4M |
Financial Cash Flow | 290M | 295.38M | 295.24M | 30.19M | 26.74M | 20.79M | 20.92M | -444K | n/a | -2K | 3.17M | 76.45M | 133.01M | 133.94M | 132M |
Net Cash Flow | 3.7M | -4.91M | 29.27M | 3.56M | 5.17M | -8.21M | -9.92M | -55.57M | -56.72M | -63.15M | -85.81M | 11.03M | 75.24M | 90.53M | 120.85M |
Free Cash Flow | -65.93M | -58.63M | -52.95M | -50.87M | -49.51M | -46.08M | -41.13M | -38.06M | -34.07M | -30.36M | -27M | -24.72M | -20.5M | -15.4M | -11.15M |